DrugPatentWatch Database Preview
Drugs in Development Information for Lymecycline
» See Plans and Pricing
What is the drug development status for Lymecycline?
Lymecycline is an investigational drug.
There have been 3 clinical trials for Lymecycline.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.
The most common disease conditions in clinical trials are Uterine Cervicitis, Urethritis, and Pleuropneumonia. The leading clinical trial sponsors are Ostergotland County Council, Sweden, Statens Serum Institut, and Galderma.
Summary for Lymecycline
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,186 |
| WIPO Patent Applications | 2,017 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 3 (2010-02-01) |
| Vendors | 0 |
Recent Clinical Trials for Lymecycline
| Title | Sponsor | Phase |
|---|---|---|
| Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced | Statens Serum Institut | Phase 4 |
| Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced | Ostergotland County Council, Sweden | Phase 4 |
| Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris | Galderma | Phase 3 |
Clinical Trial Summary for Lymecycline
Top disease conditions for Lymecycline
Top clinical trial sponsors for Lymecycline
US Patents for Lymecycline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
